絞り込み

16634

広告

「vonoprazan」の検索結果

200件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

A meta-analysis: the efficacy of vonoprazan for management of post-ESD ulcers compared with PPIs.

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

[Refractory eosinophilic gastroenteritis with gastritis, duodenal ulcer, and colitis: a case report].

Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.

Current status of first- and second-line eradication therapy in the metropolitan area: a multicenter study with a large number of patients.

A Triple-Drug Blister-Packaged Drug with Vonoprazan Improves First-Line Eradication of Helicobacter pylori in Elderly Patients: A Retrospective Propensity Score-Matched Cohort Study.

Efficacy of Vonoprazan for Helicobacter pylori Eradication.

Current Status of Helicobacter pylori Diagnosis and Eradication Therapy in Japan Using a Nationwide Database.

Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Eradication: A Meta-Analysis of Randomized Clinical Trials.

Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.

Vonoprazan versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-effectiveness Analysis in Japan.

Efficacy of Vonoprazan for 48-Week Maintenance Therapy of Patients with Healed Reflux Esophagitis.

Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis.

Development of treatment: How do we manage antimicrobial resistance?

The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.

Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.

Vonoprazan and Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?

Current and Future Treatment of Helicobacter pylori Infections.

Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.

Inhibitory Effect of Vonoprazan on the Metabolism of [C]Prasugrel in Human Liver Microsomes.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります